Inotuzumab ozogamicin Intravenous and Paclitaxel Concentrate Injection
Determining the interaction of Inotuzumab ozogamicin Intravenous and Paclitaxel Concentrate Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
Generic Name: paclitaxel
Brand name: Onxol, Taxol
Synonyms: Paclitaxel, PACLitaxel (Conventional)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin Intravenous-Paclitaxel Intravenous
- Inotuzumab ozogamicin Intravenous-Paclitaxel Novaplus
- Inotuzumab ozogamicin Intravenous-Paclitaxel protein-bound
- Inotuzumab ozogamicin Intravenous-Paclitaxel protein-bound Intravenous
- Inotuzumab ozogamicin Intravenous-Pacnex
- Inotuzumab ozogamicin Intravenous-Pacnex LP
- Paclitaxel Concentrate Injection-Inova
- Paclitaxel Concentrate Injection-Inova 4/1 topical
- Paclitaxel Concentrate Injection-Inova 8/2 topical
- Paclitaxel Concentrate Injection-Inova ACT
- Paclitaxel Concentrate Injection-Inrebic
- Paclitaxel Concentrate Injection-Inspra